PL370271A1 - Dihydrotiafenantrenokarbonyloguanidyny, sposób ich wytwarzania, ich zastosowanie jako środka leczniczego lub diagnostycznego - Google Patents
Dihydrotiafenantrenokarbonyloguanidyny, sposób ich wytwarzania, ich zastosowanie jako środka leczniczego lub diagnostycznegoInfo
- Publication number
- PL370271A1 PL370271A1 PL03370271A PL37027103A PL370271A1 PL 370271 A1 PL370271 A1 PL 370271A1 PL 03370271 A PL03370271 A PL 03370271A PL 37027103 A PL37027103 A PL 37027103A PL 370271 A1 PL370271 A1 PL 370271A1
- Authority
- PL
- Poland
- Prior art keywords
- guanidines
- thia
- phenanthrene
- dihydro
- carbonyl
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/10—Dibenzothiopyrans; Hydrogenated dibenzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/10—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms two oxygen atoms and one sulfur atom, e.g. cyclic sulfates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10204989A DE10204989A1 (de) | 2002-02-07 | 2002-02-07 | Dihydro-thia-phenanthren-carbonyl-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL370271A1 true PL370271A1 (pl) | 2005-05-16 |
Family
ID=27618378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03370271A PL370271A1 (pl) | 2002-02-07 | 2003-01-23 | Dihydrotiafenantrenokarbonyloguanidyny, sposób ich wytwarzania, ich zastosowanie jako środka leczniczego lub diagnostycznego |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1474414B1 (pl) |
| JP (1) | JP4410564B2 (pl) |
| KR (1) | KR20040096555A (pl) |
| CN (1) | CN1319963C (pl) |
| AR (1) | AR038393A1 (pl) |
| AT (1) | ATE380805T1 (pl) |
| AU (1) | AU2003208337A1 (pl) |
| BR (1) | BR0307495A (pl) |
| CA (1) | CA2475093A1 (pl) |
| CO (1) | CO5601008A2 (pl) |
| DE (2) | DE10204989A1 (pl) |
| HR (1) | HRP20040721A2 (pl) |
| HU (1) | HUP0402595A2 (pl) |
| MA (1) | MA27171A1 (pl) |
| MX (1) | MXPA04007476A (pl) |
| NO (1) | NO20043717L (pl) |
| NZ (1) | NZ534536A (pl) |
| PE (1) | PE20030963A1 (pl) |
| PL (1) | PL370271A1 (pl) |
| RS (1) | RS69204A (pl) |
| RU (1) | RU2306311C2 (pl) |
| TW (1) | TWI268927B (pl) |
| WO (1) | WO2003066620A1 (pl) |
| ZA (1) | ZA200406015B (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200614995A (en) * | 2004-11-10 | 2006-05-16 | Nicholas Piramal India Ltd | Tricyclic guanidine derivatives as sodium-proton exchange inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60262887A (ja) * | 1984-06-11 | 1985-12-26 | Mitsubishi Chem Ind Ltd | 液晶組成物 |
| GB8505756D0 (en) * | 1985-03-06 | 1985-04-11 | Erba Farmitalia | Tricyclic dibenzo condensed derivatives |
| US4948806A (en) * | 1988-03-30 | 1990-08-14 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
| DE19601303A1 (de) * | 1996-01-16 | 1997-07-17 | Boehringer Ingelheim Kg | Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln |
| WO2000064445A1 (en) * | 1999-04-23 | 2000-11-02 | Bristol-Myers Squibb Company | Bicyclic acyl guanidine sodium/proton exchange inhibitors and method |
| DE10001879A1 (de) * | 2000-01-19 | 2001-07-19 | Aventis Pharma Gmbh | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
2002
- 2002-02-07 DE DE10204989A patent/DE10204989A1/de not_active Withdrawn
-
2003
- 2003-01-23 HU HU0402595A patent/HUP0402595A2/hu unknown
- 2003-01-23 BR BR0307495-1A patent/BR0307495A/pt not_active IP Right Cessation
- 2003-01-23 MX MXPA04007476A patent/MXPA04007476A/es active IP Right Grant
- 2003-01-23 RU RU2004126854/04A patent/RU2306311C2/ru not_active IP Right Cessation
- 2003-01-23 RS YU69204A patent/RS69204A/sr unknown
- 2003-01-23 KR KR10-2004-7012241A patent/KR20040096555A/ko not_active Withdrawn
- 2003-01-23 PL PL03370271A patent/PL370271A1/pl not_active Application Discontinuation
- 2003-01-23 CN CNB038035502A patent/CN1319963C/zh not_active Expired - Fee Related
- 2003-01-23 EP EP03706373A patent/EP1474414B1/de not_active Expired - Lifetime
- 2003-01-23 WO PCT/EP2003/000653 patent/WO2003066620A1/de not_active Ceased
- 2003-01-23 JP JP2003565993A patent/JP4410564B2/ja not_active Expired - Fee Related
- 2003-01-23 AT AT03706373T patent/ATE380805T1/de not_active IP Right Cessation
- 2003-01-23 HR HR20040721A patent/HRP20040721A2/hr not_active Application Discontinuation
- 2003-01-23 NZ NZ534536A patent/NZ534536A/en unknown
- 2003-01-23 AU AU2003208337A patent/AU2003208337A1/en not_active Abandoned
- 2003-01-23 DE DE50308787T patent/DE50308787D1/de not_active Expired - Lifetime
- 2003-01-23 CA CA002475093A patent/CA2475093A1/en not_active Abandoned
- 2003-01-30 TW TW092102087A patent/TWI268927B/zh not_active IP Right Cessation
- 2003-02-05 AR ARP030100363A patent/AR038393A1/es unknown
- 2003-02-05 PE PE2003000136A patent/PE20030963A1/es not_active Application Discontinuation
-
2004
- 2004-07-27 MA MA27802A patent/MA27171A1/fr unknown
- 2004-07-28 ZA ZA200406015A patent/ZA200406015B/en unknown
- 2004-08-06 CO CO04076743A patent/CO5601008A2/es not_active Application Discontinuation
- 2004-09-06 NO NO20043717A patent/NO20043717L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003208337A1 (en) | 2003-09-02 |
| PE20030963A1 (es) | 2004-01-12 |
| BR0307495A (pt) | 2004-12-28 |
| CA2475093A1 (en) | 2003-08-14 |
| HK1073656A1 (en) | 2005-10-14 |
| RU2306311C2 (ru) | 2007-09-20 |
| HRP20040721A2 (en) | 2005-06-30 |
| TW200404792A (en) | 2004-04-01 |
| ATE380805T1 (de) | 2007-12-15 |
| CO5601008A2 (es) | 2006-01-31 |
| EP1474414A1 (de) | 2004-11-10 |
| DE50308787D1 (de) | 2008-01-24 |
| CN1630649A (zh) | 2005-06-22 |
| ZA200406015B (en) | 2005-11-14 |
| TWI268927B (en) | 2006-12-21 |
| CN1319963C (zh) | 2007-06-06 |
| NO20043717L (no) | 2004-11-03 |
| DE10204989A1 (de) | 2003-08-21 |
| JP2005517015A (ja) | 2005-06-09 |
| JP4410564B2 (ja) | 2010-02-03 |
| HUP0402595A2 (hu) | 2005-04-28 |
| RU2004126854A (ru) | 2006-01-27 |
| AR038393A1 (es) | 2005-01-12 |
| MXPA04007476A (es) | 2004-11-10 |
| WO2003066620A1 (de) | 2003-08-14 |
| EP1474414B1 (de) | 2007-12-12 |
| KR20040096555A (ko) | 2004-11-16 |
| MA27171A1 (fr) | 2005-01-03 |
| NZ534536A (en) | 2006-02-24 |
| RS69204A (sr) | 2006-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1400056I1 (hu) | Glükopiranozil-helyettesített benzol-származékok, az említett vegyületeket tartalmazó gyógyszerek, azok alkalmazása, és eljárás elõállításukra | |
| IL181012A0 (en) | Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments | |
| PL378065A1 (pl) | Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych | |
| AP2005003288A0 (en) | Process for the preparation os (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine | |
| IL191988A0 (en) | Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof | |
| ZA200409381B (en) | Ring-substituted diphenyl azetidones, method for the production thereof, medicaments containing said compounds, and use thereof | |
| PL376399A1 (pl) | Nowe związki pirydopirymidynowe, proces ich wytwarzania i zawierające je mieszanki farmaceutyczne | |
| IL162316A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t | |
| ZA200302310B (en) | A process for preparing a catalyst, the catalyst and a use of the catalyst. | |
| PL371784A1 (pl) | Pentafluorotio-benzoiloguanidyny, sposób ich wytwarzania, ich zastosowanie jako środka leczniczego lub diagnostycznego oraz środek leczniczy zawierający te związki | |
| IL150228A0 (en) | Substituted norbornylamino derivatives, method for the production thereof, use thereof as medicament or a diagnostic reagent and medicaments containing said compounds | |
| ZA200409095B (en) | Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same. | |
| PT1838683E (pt) | Um processo para a preparação de derivados de [1,4,5]-oxadiazepina | |
| EP1561434A4 (en) | BITE ATTACHMENT, BIT AND MANUFACTURING PROCESS THEREFOR | |
| IL174438A0 (en) | Phenylacetic acid derivative, process for producing the same, and use | |
| ZA200601001B (en) | Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicament comprising the same | |
| EG23417A (en) | Process for the preparation 7 a-methylsteroids. | |
| IL174975A0 (en) | 2-phenyl-benzofuran derivatives, method for the production thereof and their use | |
| IL162562A0 (en) | Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolid | |
| IL181556A0 (en) | Pentafluorosulfanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds | |
| ZA200600718B (en) | 1-Carbamoylcycloalkylcarboxylic acid compounds, processes for making and uses thereof | |
| SI1513834T1 (sl) | Substituirani tiofeni, postopek za njihovo pripravo, njihova uporaba kot zdravilo ali kot diagnostik kot tudi zdravilo, ki jih vsebuje | |
| ZA200205696B (en) | Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same. | |
| PL363247A1 (pl) | Manipulator, zwłaszcza manipulator medyczny | |
| SI1509498T1 (sl) | Pentafluorosulfanil-benzoilgvanidini, postopek za njihovo pripravo, njihova uporaba kot zdravilo ali diagnosticno sredstvo in zdravilo, ki jih vsebuje |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |